BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 28035426)

  • 1. Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.
    Kamagata K; Nakatsuka T; Sakakibara R; Tsuyusaki Y; Takamura T; Sato K; Suzuki M; Hori M; Kumamaru KK; Inaoka T; Aoki S; Terada H
    Neuroradiology; 2017 Jan; 59(1):89-98. PubMed ID: 28035426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
    McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
    Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
    Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
    Shimizu S; Kanetaka H; Hirao K; Fukasawa R; Namioka N; Hatanaka H; Hirose D; Umahara T; Sakurai H; Hanyu H
    Geriatr Gerontol Int; 2017 May; 17(5):819-824. PubMed ID: 27138074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
    McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
    Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diagnostic utility of semi-quantitative analysis for DAT-SPECT for distinguishing DLB from AD.
    Shimizu S; Namioka N; Hirose D; Kanetaka H; Hirao K; Hatanaka H; Takenoshita N; Kaneko Y; Ogawa Y; Tsugawa A; Umahara T; Sakurai H; Hanyu H
    J Neurol Sci; 2017 Jun; 377():50-54. PubMed ID: 28477707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.
    Walker Z; Jaros E; Walker RW; Lee L; Costa DC; Livingston G; Ince PG; Perry R; McKeith I; Katona CL
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1176-81. PubMed ID: 17353255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
    Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
    Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
    J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
    Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
    Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Iizuka T; Kameyama M
    Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia.
    Spehl TS; Frings L; Hellwig S; Weiller C; Hüll M; Meyer PT; Amtage F
    Clin Nucl Med; 2015 Jan; 40(1):e27-33. PubMed ID: 25140560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies.
    Walker RW; Walker Z
    Mov Disord; 2009; 24 Suppl 2():S754-9. PubMed ID: 19877236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT.
    Imabayashi E; Soma T; Sone D; Tsukamoto T; Kimura Y; Sato N; Murata M; Matsuda H
    Ann Nucl Med; 2017 Aug; 31(7):536-543. PubMed ID: 28547521
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Pardini M; Nobili F; Arnaldi D; Morbelli S; Bauckneht M; Rissotto R; Serrati C; Serafini G; Lapucci C; Ghio L; Amore M; Massucco D; Sassos D; Bonzano L; Mancardi GL; Roccatagliata L;
    Eur Radiol Exp; 2020 May; 4(1):27. PubMed ID: 32363488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand.
    Walker Z; Costa DC; Walker RW; Shaw K; Gacinovic S; Stevens T; Livingston G; Ince P; McKeith IG; Katona CL
    J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):134-40. PubMed ID: 12122169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between clinical symptoms and striatal DAT uptake in patients with DLB.
    Shimizu S; Hirose D; Namioka N; Kanetaka H; Hirao K; Hatanaka H; Takenoshita N; Kaneko Y; Ogawa Y; Umahara T; Sakurai H; Hanyu H
    Ann Nucl Med; 2017 Jun; 31(5):390-398. PubMed ID: 28361209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Swallow Tail Sign on Susceptibility-Weighted Imaging in Dementia with Lewy Bodies.
    Rizzo G; De Blasi R; Capozzo R; Tortelli R; Barulli MR; Liguori R; Grasso D; Logroscino G
    J Alzheimers Dis; 2019; 67(1):61-65. PubMed ID: 30475767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
    Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.